WEINHOFF GREGORY M (Chief Financial Officer) sold 26.7% of their position (24K shares) of CENTESSA PHARMACEUTICALS PLC on the open market
Open‑market sale worth $719.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001470831-26-000320
Officer· Chief Financial Officer
Since May 2021
-24K
Net shares
Net seller
$719.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
24K acquired · 48K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+24K
Price / share
$3.85
Trade value
$92.39K
% of position
36.4%
3/26/2026
65.92K→89.92K
Ordinary Shares
Direct
Shares
−24K
Price / share
$30.00
Trade value
$719.94K
% of position
26.7%
3/26/2026
89.92K→65.92K
Total
Net shares
+0.00
Net value
-$627.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/26/2026 | M · Option Exercise | +24K | $3.85 | $92.39K | 36.4% | 65.92K | 89.92K |
| Ordinary Shares Direct | 3/26/2026 | S · Sale | −24K | $30.00 | $719.94K | 26.7% | 89.92K | 65.92K |
| Total | +0.00 | -$627.55K | ||||||
Derivative Transactions1
Share Option (right to buy)
Direct
Converts to
Ordinary Shares
24K shares
Shares
−24K
Strike price
3.85
Held after
31K
Exercisable
—
3/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares24K shares | 3/26/2026 | M · Option Exercise | −24K | 3.85 | — | 31K |